A unique partnership accelerating lifesaving innovation

UK CEiRSI connects science, regulation and industry so that computational evidence can be trusted, accepted and used.

Our history

UK CEiRSI stemmed from years of UK leadership in computational science, health data and regulatory policy.

Recognising the global shift towards in-silico innovation, leading UK universities and national partners joined forces to address a critical gap: credible, trusted use of virtual evidence in medical regulation.

Headquartered at the University of Manchester with partners across Cambridge, Edinburgh, Oxford, Strathclyde, UCL and York universities, UK CEiRSI was formally launched in 2025 with £1 million UKRI funding, backed by the MHRA. NICE, the HRA, BSI and NPL also support the Centre.

We connect science, regulation and industry to accelerate adoption and shape the future of evidence-based healthcare innovation and wider prosperity.

Vision

To establish the UK as the global leader in in-silico regulatory science, where computational evidence revolutionises healthcare innovation and regulation and every patient benefits.

Mission

We accelerate lifesaving innovation through a unique partnership that pioneers computational regulatory science, transforming how medical devices and medicines reach patients – faster, safer and more equitably.

About this community

Reports, technical notes, white papers and recordings from UK CEiRSI, each with a citable DOI. More at www.uk-ceirsi.org.